Bengaluru, Nov. 3 -- Shares of a research-based global pharmaceutical and biotech company surged nearly 12 percent on Monday, after reporting Q2 FY26 financial results, marking a strong financial turnaround with a net profit of Rs. 82 crores compared to losses in both the previous quarter and the same period last year.

With a market cap of Rs. 22,991 crores, shares of Wockhardt Limited closed in the green at Rs. 1,414.95 on BSE, up by around 10.4 percent, compared to its previous closing price of Rs. 1,281.3.

The stock has delivered positive returns of over 8 percent in one year, but has fallen by nearly 3 percent in the last one month.

What's the News:

Wockhardt Limited announced the financial results for the second quarter of FY26 o...